CMPXCompass Therapeutics, Inc.

$764M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$6M

Net Income

-$6M

EPS (Diluted)

$-0.10

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$4M

Stock-Based Comp.

$987,000

Balance Sheet

Total Assets

$35M

Total Liabilities

$11M

Stockholders' Equity

$24M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$6M	-$9M	+34.7%
Net Income	-$6M	-$9M	+34.7%

CMPX Q3 2021 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena